Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Total Assets
Current Liabilities:
Accounts payable	316,400	316,400
Accrued liabilities	1,278,175	1,193,596
Accrued officer compensation	202,000	172,000
Convertible Notes, net of discounts of $0 and $209,029, respectively	1,729,395	1,693,848
Derivative liabilities	452,667	472,605
Loans payable	254,500	254,500
Total Current Liabilities	4,233,138	4,102,949
Total Liabilities	4,233,138	4,102,949
Commitments and Contingencies (Note 9)
MEZZANINE EQUITY
Series E Preferred stock, 500,000 shares authorized, par value $0.01; 34,985 and 53,000 shares issued and outstanding; respectively	34,985	34,985
Series E Preferred stock to be issued	166,331	140,831
Total mezzanine equity	201,316	201,316
Stockholders' Equity (Deficit):
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding	33,815	33,815
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding	50	50
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding	50,000	50,000
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding	12	12
Common stock 3,000,000,000 shares authorized, $0.00001 par value; 297,041,945 and 297,041,945 shares issued and outstanding, respectively	2,970	2,970
Treasury stock, at cost - 2,917 shares	(773,500)	(773,500)
Additional paid in capital	75,958,049	75,958,049
Accumulated deficit	(79,705,851)	(79,575,663)
Total Stockholders' Deficit	(4,233,138)	(4,102,949)
Total Liabilities and Stockholders' Deficit